March 19, 2013

TB Alliance Licenses Late-stage TB Program to CSIR-OSDD

OSDD to assume development, commercialization for promising TB regimen
March 17, 2013

UNITAID and TB Alliance Call For More Action Against Childhood Tuberculosis

In TB Fight, Children Must Be a Priority
March 17, 2013

World TB Day 2013 Toolkit

Get Involved Now
March 3, 2013

David Norton Appointed to TB Alliance’s Board of Directors

Former Johnson & Johnson Chairman of Pharmaceuticals brings global product development and commercialization expertise
February 24, 2013

PSI CEO Karl Hofmann Elected President of TB Alliance’s Stakeholders Association, Joins Board of Directors

Global health expert and diplomat to lend skills, support to optimize new TB drug introductions
January 10, 2013

Improving the Therapeutic Potential of Pyrazinamide

US NIH AIDS Clinical Trials Group Grant Supports the Investigation of Methods to Overcome Drug-Resistance and Reduce Toxicity of TB Treatment
January 6, 2013

TB Alliance Announces TB Veteran Dr. Carlos Morel as Chairman of its Board of Directors

Board leadership brings unparalleled experience in the field